# BRAINSTORM CELL THERAPEUTICS (BCLI)

> Institutional ownership reported to the SEC as of Q3 2025, from Form 13F filings. Source: https://holderbook.com/stocks/BCLI/

- Reporting holders: 5
- Reported value: $1.7K
- Shares held by institutions: 2,317 of 11,034,775 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [OSAIC HOLDINGS, INC.](https://holderbook.com/funds/1677044-osaic-holdings-inc/) | $1.4K | 1,785 | 0.0% | 4 |
| [Bangor Savings Bank](https://holderbook.com/funds/1352675-bangor-savings-bank/) | $188 | 266 | 0.0% | 3 |
| [VSM Wealth Advisory, LLC](https://holderbook.com/funds/2050660-vsm-wealth-advisory-llc/) | $85 | 120 | 0.0% | 3 |
| [Steward Partners Investment Advisory, LLC](https://holderbook.com/funds/1723397-steward-partners-investment-advisory-llc/) | $80 | 113 | 0.0% | 4 |
| [ST GERMAIN D J CO INC](https://holderbook.com/funds/831571-st-germain-d-j-co-inc/) | $23 | 33 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2025 | 5 | $1.7K |
| Q2 2025 | 33 | $264.0K |
| Q1 2025 | 31 | $1.1M |
| Q4 2024 | 34 | $583.5K |
| Q3 2024 | 40 | $2.6M |
| Q2 2024 | 48 | $4.2M |
| Q1 2024 | 46 | $2.3M |
| Q4 2023 | 47 | $1.1M |
| Q3 2023 | 56 | $2.0M |
| Q2 2023 | 60 | $17.1M |
| Q1 2023 | 47 | $22.9M |
| Q4 2022 | 44 | $7.1M |